Pilot study of efficacy and safety of Rikkunshito for adverse events (nausea, emesis and anorexia) caused by chemotherapy (modified MAID therapy) for high grade bone and soft tissue sarcomas.
Not Applicable
- Conditions
- High-grade bone and soft tissue sarcomas
- Registration Number
- JPRN-UMIN000015113
- Lead Sponsor
- Tokyo Metropolitan Komagome Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients with double cancer 2. Patients who took Kampo within 4 weeks 3. Patients with any other severe diseases 4. Pregnat patients 5. Other exclusionary comobidity
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method